Events

TGA presentation slides from Virtual Public-Private Dialogue (PPD) on Biotechnological products in partnership with Peru INS (11 May 2021).

Special Access Scheme - portal updates.

An overview of TGA's proposed safety and quality requirements for unapproved vaporiser nicotine products.

Guidance for industry on the new regulatory framework for personalised medical devices commencing on 25 February 2021.

SME Assist's 'Meeting Your Obligations' workshop - Live stream - 22 October 2020 has now been published.

This presentation provides an overview of TGA's comparable overseas regulator pathways and international work-sharing activities for prescription medicines.

Remote Inspections from TGA perspective - Impact of Covid-19 Restrictions on Manufacturers and Test Laboratories.

Information session for consumers and health practitioners on proposed changes to the way nicotine is supplied.

Information session for consumers and health practitioners on proposed changes to the way nicotine is supplied.

Information session for suppliers on proposed changes to the way nicotine is supplied.

Webinar presentation, recordings and frequently asked questions to explain the proposed changes to the way nicotine is supplied.

A panel discussion was held in Sydney to talk about BIA-ALCL and breast reconstructive surgery. The recording of this discussion is below.

A panel discussion was held in Sydney to talk about BIA-ALCL and breast augmentations. The recording of this discussion is below.

Registration open

An overview of medical device software regulation in Australia.